You're Getting Sick Constantly. Here's the Biological Reason.

TLR4 is a receptor that sits on the surface of your immune cells like an alarm system. Its job is to detect bacterial lipopolysaccharides (LPS), which are components of gram-negative bacteria, within the first few hours of exposure. When it sees LPS, it triggers an immediate inflammatory response to contain the threat before it can spread.

The TLR4 D299G variant, carried by roughly 10% of people with European ancestry, changes the shape of this receptor. It can’t recognize LPS as effectively, which means your immune system may not realize you’ve been exposed to a bacterial threat for 12 to 48 hours after infection actually begins. By that time, the bacteria have already multiplied significantly and spread deeper into your tissues.

The result: bacterial infections take longer to develop symptoms, progress more aggressively once they do start, and are harder to recover from. Sinus infections, urinary tract infections, and respiratory infections are the most common complaints. You often don’t feel sick until the infection is already well established.

FUT2 controls what sugars are secreted in your mucus and saliva, which in turn determines which bacteria are able to colonize your gut. This isn’t abstract: your gut bacteria are your first immune defense. Friendly bacteria occupy space and produce compounds that train your immune system and prevent pathogens from establishing a foothold. FUT2 determines whether your gut environment attracts helpful bacteria or creates a welcome mat for invaders.

The FUT2 non-secretor variant, present in roughly 40-50% of the population depending on ancestry, means your mucus chemistry creates an environment where protective bacteria struggle to thrive. Without the right bacterial allies in your gut, your immune system is flying solo against pathogens that would normally be outcompeted by your microbiome. Your gut barrier is weaker and your immune system has to work harder just to maintain baseline defense.

In practical terms: you catch viral infections more frequently (especially respiratory viruses), you recover more slowly, and you may experience more digestive upset during and after infections. You’re also more prone to food poisoning and traveler’s diarrhea because your gut can’t resist foodborne pathogens as effectively.

VDR is the vitamin D receptor. It’s not just about bone health. When vitamin D binds to VDR, it activates a cascade of immune genes that train your T-cells, activate macrophages to kill intracellular pathogens, and regulate inflammatory response intensity. VDR is also crucial for maintaining your gut barrier and the integrity of the blood-brain barrier. A functional VDR is how vitamin D actually protects you from infection.

Common VDR variants (such as the FokI polymorphism), carried by roughly 50% of the population, produce a shorter or longer version of the VDR protein. The shorter version is generally more active and efficient. People carrying variants that produce longer, less-efficient VDR versions require higher circulating vitamin D levels to achieve the same immune-protective effect. You might be in the normal range for vitamin D on a standard test and still be functionally deficient for immune function.

The lived experience: you get worse seasonal infections (especially during winter or in low-sun climates), you take longer to recover from illness, and your immune response feels slow-building and sluggish. Vitamin D supplementation helps, but you need higher doses than someone without the variant.

HLA-DQ2 is part of your Major Histocompatibility Complex (MHC), which is your immune system’s passport control. It presents antigens (pieces of invaders) to your T-cells so they can decide whether to attack or leave alone. A functional HLA-DQ2 means your adaptive immune system can build accurate memory of pathogens you’ve encountered and respond faster the second time around. This is why vaccination works and why you typically don’t get chickenpox twice.

HLA-DQ2 is present in roughly 25-30% of people with European ancestry. Here’s the critical detail: HLA-DQ2 isn’t just about normal immune response. It’s also required for celiac disease susceptibility and is associated with increased risk for type 1 diabetes and other autoimmune conditions. If you carry HLA-DQ2, your immune system is simultaneously less able to distinguish between self and non-self, and more prone to autoimmune activation. This creates a paradox: you might struggle with infections while also being at higher risk for inappropriate immune attacks on your own tissues.

In daily life: you get frequent infections (especially viral), you may have a history of autoimmune conditions or food sensitivities, and your recovery from illness is often complicated by prolonged inflammation or post-viral fatigue.

TNF (tumor necrosis factor-alpha) is one of your body’s most powerful inflammatory signaling molecules. It tells immune cells to activate, to attack invaders, to increase blood vessel permeability so immune cells can reach infected tissues. In short bursts, TNF is essential. But TNF also drives systemic inflammation, causes tissue damage if overproduced, and is a risk factor for chronic inflammatory disease.

The TNF -308G>A variant, carried by roughly 30% of people of European ancestry, increases baseline TNF-alpha production. Your immune system is essentially running on a higher inflammatory setting all the time. When you’re fighting an infection, this higher baseline means your inflammatory response becomes excessive; you produce more TNF than necessary to eliminate the threat, causing collateral tissue damage and prolonging recovery time.

What this means practically: when you get sick, you feel sicker than other people seem to. Higher fevers, worse body aches, prolonged malaise even after the infection is cleared. You recover more slowly because the inflammation itself becomes the problem. You might also notice you’re prone to post-viral fatigue, where you feel exhausted for weeks after a routine illness.

IL1B (Interleukin-1 beta) is released by immune cells immediately when they detect a threat. It’s one of the first inflammatory signals your body sends, before TNF, before the full adaptive immune cascade. IL1B tells your brain to raise your temperature (fever is useful), tells your blood vessels to allow immune cells through, and amplifies the entire inflammatory response.

The IL1B rs16944 variant, present in roughly 35-40% of the population, increases IL1B production. Your immune system responds more aggressively to pathogens. But here’s the catch: this heightened response comes with a cost, because excessive IL1B also drives the inflammatory consequences of infection, not just the beneficial parts. You mount a vigorous immune response, yes, but at the expense of greater fever, worse systemic symptoms, and higher risk of post-infection complications like secondary bacterial infections.

You experience this as: intense symptoms when you do get sick (high fevers, significant body aches, chills), but sometimes faster initial recovery because your immune system is more aggressive. However, you’re also prone to bouncing between infections, because the excessive inflammation leaves you immunologically exhausted. You catch one thing, get hit hard, recover partially, then immediately catch something else.